[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353794-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353794-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ror-drives-non-small-cell-lung-cancer-progression-by-upregulating-the-ngf-signaling","RORγ drives non-small cell lung cancer progression by upregulating the NGF signaling","","Non-small cell lung cancer (NSCLC) remains highly lethal, and novel therapeutic targets are urgently needed. This study investigates retinoic acid receptor-related orphan receptor gamma (RORγ) in NSCLC, integrating public bioinformatics, immunohistochemistry, and Western blot to link RORγ expression with prognosis. Functional assays assess proliferation, migration, and invasion, while RNA sequencing, chromatin immunoprecipitation, and NGF rescue experiments clarify mechanism and validate anti-tumor effects in vivo using xenograft and metastasis models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ror-drives-non-small-cell-lung-cancer-progression-by-upregulating-the-ngf-signaling/353794/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ror-drives-non-small-cell-lung-cancer-progression-by-upregulating-the-ngf-signaling/353794.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does RORγ play in NSCLC progression?","Question",{"text":63,"@type":64},"RORγ is identified as a key driver of NSCLC progression, with higher expression in NSCLC tissues correlating with poor prognosis and promoting malignant cell behaviors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the relationship between RORγ and patient prognosis evaluated?",{"text":68,"@type":64},"The study combined public database bioinformatics with immunohistochemistry and Western blot to assess RORγ expression and correlate it with patient outcomes.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism connects RORγ to NGF signaling in NSCLC?",{"text":72,"@type":64},"RORγ directly binds the NGF promoter region, stimulates NGF transcription, and thereby promotes NSCLC progression; NGF supplementation or NGF overexpression reverses the inhibitory effects of RORγ antagonists.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353794,1791128271,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Zeng et al. Respiratory Research (2026) 27:101 [https://doi.org/10.1186/s12931-026-03523-7](https://doi.org/10.1186/s12931-026-03523-7)  \nRespiratory Research  \nRESEARCH Open Access  \nRORγ drives non-small cell lung cancer progression by upregulating the NGF signaling  \nYechun Zeng1†, Guodi Cai1†, Jian Zhang2†, Zhenhua Zhang1, Wenxin Yin3, Tianmiao Ou1, Meng Xu4, Jing Li5, Zhanfang Kang6, Junguo Bu7, Junjian Wang1,8*, Jie Huang9* and Weineng Feng4*  \nAbstract  \nBackground Lung cancer remains one of the most prevalent and lethal malignancies worldwide, with non-small cell lung cancer (NSCLC) representing the most common subtype—highlighting the critical need for novel therapeutic approaches. The retinoic acid receptor-related orphan receptor gamma (RORγ) has been implicated in various cancers, but its role and mechanism in NSCLC remain unclear.  \nMethods RORγ expression and its correlation with patient prognosis in NSCLC were assessed by integrating public database bioinformatics analysis, immunohistochemistry, and Western blot. The functional roles of RORγ in NSCLC proliferation, migration, and invasion were determined in vitro through genetic overexpression, pharmacological inhibition, or genetic silencing of RORγ, assessed by cell counting, colony formation, wound healing, and transwell assays. The underlying mechanism was investigated using RNA sequencing, chromatin immunoprecipitation, and rescue experiments with exogenous nerve growth factor (NGF) supplementation or NGF overexpression. In vivo, the anti-tumor efficacy of RORγ inhibition was evaluated using subcutaneous xenograft and experimental metastasis models.  \nResults We identify RORγ as a key driver of NSCLC progression. Integrative bioinformatics and immunohistochemical analysis revealed that RORγ is highly expressed in NSCLC tissues and that its expression correlates with poor patient prognosis. Functionally, elevated RORγ significantly enhanced the proliferation, migration, and invasion capabilities of NSCLC cells. Conversely, treatment with the RORγ antagonist or genetic silencing of RORγ potently suppressed these malignant phenotypes both in vitro and in vivo. Mechanistically, RORγ directly binds to the promoter region of NGF, stimulates NGF gene transcription, and thereby promotes NSCLC progression. RORγ antagonists suppress  \n†Yechun Zeng, Guodi Cai and Jian Zhang contributed equally to this work.  \n*Correspondence:  \nJunjian Wang [wangjj87@mail.sysu.edu.cn](wangjj87@mail.sysu.edu.cn)[ ](wangjj87@mail.sysu.edu.cn)Jie Huang [huangjie@gdph.org.cn](huangjie@gdph.org.cn)[ ](huangjie@gdph.org.cn)Weineng Feng [fengweineng@163.com](fengweineng@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nZeng et al. Respiratory Research (2026) 27:101 Page 2 of 15  \nNGF expression and inhibit its downstream signaling pathways, whereas exogenous NGF supplementation or overexpression of NGF notably reverses the inhibitory effects of RORγ antagonists on NSCLC cells.  \nConclusion Taken together, ","cbCaiijVzIEbq7Qp","https://ap.wps.com/l/cbCaiijVzIEbq7Qp","pdf",11395450,15,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What role does RORγ play in NSCLC progression?\",\"answer\":\"RORγ is identified as a key driver of NSCLC progression, with higher expression in NSCLC tissues correlating with poor prognosis and promoting malignant cell behaviors.\"},{\"question\":\"How was the relationship between RORγ and patient prognosis evaluated?\",\"answer\":\"The study combined public database bioinformatics with immunohistochemistry and Western blot to assess RORγ expression and correlate it with patient outcomes.\"},{\"question\":\"What mechanism connects RORγ to NGF signaling in NSCLC?\",\"answer\":\"RORγ directly binds the NGF promoter region, stimulates NGF transcription, and thereby promotes NSCLC progression; NGF supplementation or NGF overexpression reverses the inhibitory effects of RORγ antagonists.\"}]","RORγ drives non-small cell lung cancer progression by upregulating the NGF signaling | PDF",1790107266,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da6068c21725fe460c95fa032fe3b370.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c15b1063e2476cfb1260e12d963641c6.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aefaa036b46ef1f3b903732950dfcaca.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbc45d102f892a3eee469ddded37ed28.webp",980,1306]